Miller 2001.
Methods | Single‐blind RCT. | |
Participants | Number screened: 29. Number included: 20. Number followed up: 20. Number of withdrawals: 2 from treatment, 1 did not complete all testing. Diagnosis of DCD: by a physician. Presence and absence of comorbid conditions: excluded children with medical diagnosis of a specific neurological disorder or a physical or sensory deficit causing the motor problem. Regarding participants completing the study Age (mean ± SD): CO‐OP: 8.90 ± 1.52 years (range 7 to 12 years), CTA: 9.20 ± 0.92 years (range 7 to 12 years). Sex: 14 boys, 6 girls. Ethnicity: no information. Country: Canada. Setting: Cloverleaf Research and Treatment Clinic in School of Occupational Therapy at University of Western Ontario. Sociodemographics: no information. Inclusion criteria
Exclusion criteria
|
|
Interventions |
Comparison: CO‐OP vs CTA. Intervention schedule: 50 min for 10 sessions, no frequency information. Duration of intervention: no information. Mode of delivery: face‐to‐face individual sessions. Intervention material: CO‐OP: GPDC strategy and its application to target tasks; CTA: target tasks practise under skill direction and corrections. Intervention procedure: CO‐OP: self‐talk and problem‐solving strategies are used to solve motor problems and applied to new situations; CTA: children were instructed in the performance of the task and the therapist actively provided skill direction and corrective instructions for problematic motor components. Intervention provider: 1 therapist experienced in the administration of CO‐OP and 2 therapists experienced in the administration of CTA. Place of intervention: Cloverleaf Research and Treatment Clinic in School of Occupational Therapy at University of Western Ontario. Intervention compliance: monitored by investigators. 1 mid‐point treatment session was video‐taped to check adherence of treatment protocol. |
|
Outcomes |
Primary
Secondary
Adverse effects or events: no adverse effect.* Measures of participation: not reported. |
|
Notes | Study start date: not available. Study completion date: not available. Sample calculation: to be conducted based on the pilot study. Ethics approval: no information. Comments from study authors Limitations:
Key conclusions of study authors CO‐OP more effective than CTA. Comment from review authors A high dropout rate (> 10%) with no explanation as to reasons and group affiliations. * Email correspondence with study authors: May 2016. We wrote to the study authors twice to request supplementary information on data and obtained supplementary information. Follow‐up data obtained for 8 participants in CO‐OP group and 7 in CTA group. Follow‐up intervals varied from 7.5 months to 13 months. No inactive control group. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | System of random envelopes. |
Allocation concealment (selection bias) | Unclear risk | Not stated. |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Impossible to blind participants. |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | 3 independent assessors. |
Incomplete outcome data (attrition bias) All outcomes | High risk | 3 dropouts from intervention, 1 did not complete all required testing. |
Selective reporting (reporting bias) | Low risk | No protocol obtained. All prespecified outcomes of interest reported. |
Other bias | Low risk | Funding: research funded by a research grant from the Hospital for Sick Children Foundation Toronto, Ontario. Conflicts of interest: no information available. Small numbers. |